These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16230717)

  • 21. [Cost saving program instead of optimizing therapy: disease mismanagement in diabetes mellitus? (interview by Dr. med. Jochen Aumiller)].
    Rett K
    MMW Fortschr Med; 2005 Jun; 147(22):15. PubMed ID: 15977626
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus.
    Janka HU; Plewe G; Busch K
    J Am Geriatr Soc; 2007 Feb; 55(2):182-8. PubMed ID: 17302653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
    Lind M; Hirsch IB; Tuomilehto J; Dahlqvist S; Ahrén B; Torffvit O; Attvall S; Ekelund M; Filipsson K; Tengmark BO; Sjöberg S; Pehrsson NG
    BMJ; 2015 Oct; 351():h5364. PubMed ID: 26512041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [When injectable diabetes therapy becomes necessary. Insulin or GLP-1 analogs?].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Jan; 153(1-2):14. PubMed ID: 24761480
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypoglycemia--simply annoying or dangerous?].
    Kern W
    MMW Fortschr Med; 2016 Jun; 158(11):67-70. PubMed ID: 27271419
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypoglycemia and blood glucose fluctuations in the application of a sensor-augmented insulin pump.
    Luo P; Cheng Q; Chen B; Li Y; Wu J; Zhang X; Jiao X; Zhao J; Lv X
    Diabetes Technol Ther; 2013 Dec; 15(12):984-9. PubMed ID: 24004044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Starting insulin therapy in type 2 diabetes: lesson 1.
    McCall AL
    Curr Diab Rep; 2005 Oct; 5(5):325-6. PubMed ID: 16188164
    [No Abstract]   [Full Text] [Related]  

  • 28. Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.
    Rosenstock J; Lorber DL; Gnudi L; Howard CP; Bilheimer DW; Chang PC; Petrucci RE; Boss AH; Richardson PC
    Lancet; 2010 Jun; 375(9733):2244-53. PubMed ID: 20609970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Summaries for patients: Dapagliflozin treatment in patients with inadequately controlled type 2 diabetes despite the use of insulin.
    Ann Intern Med; 2012 Mar; 156(6):I-44. PubMed ID: 22431686
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center.
    Cander S; Dizdar OS; Oz Gul O; Guclu M; Unal OK; Tuncel E; Erturk E; Imamoglu S; Ersoy C
    Prim Care Diabetes; 2014 Oct; 8(3):256-64. PubMed ID: 24522170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initiating insulin therapy in elderly patients with Type 2 diabetes: efficacy and safety of lispro mix 25 vs. basal insulin combined with oral glucose-lowering agents.
    Wolffenbuttel BH; Klaff LJ; Bhushan R; Fahrbach JL; Jiang H; Martin S
    Diabet Med; 2009 Nov; 26(11):1147-55. PubMed ID: 19929994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple therapeutic combination for type 2 diabetes.
    Yki-Järvinen H
    Hosp Pract (1995); 2000 Jul; 35(7):63-6, 72-4. PubMed ID: 10916505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: A retrospective claims analysis.
    Lynch P; Riedel AA; Samant N; Fan Y; Peoples T; Levinson J; Lee SW
    Prim Care Diabetes; 2010 Dec; 4(4):209-14. PubMed ID: 20832374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.
    Yki-Järvinen H; Dressler A; Ziemen M;
    Diabetes Care; 2000 Aug; 23(8):1130-6. PubMed ID: 10937510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Summaries for patients: Does adding exenatide to insulin treatment benefit patients with type 2 diabetes?
    Ann Intern Med; 2011 Jan; 154(2):I-40. PubMed ID: 21135289
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin regimens in type 2 diabetes.
    Lund SS; Vaag AA
    N Engl J Med; 2010 Mar; 362(10):959; author reply 960. PubMed ID: 20220196
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.
    Jacober SJ; Scism-Bacon JL; Zagar AJ
    Diabetes Obes Metab; 2006 Jul; 8(4):448-55. PubMed ID: 16776752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of daily plasma glucose control in type 2 diabetes.
    Pollom RD
    J Fam Pract; 2009 Aug; 58(8 Suppl):S10-7. PubMed ID: 19679026
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin.
    Petrak F; Herpertz S; Stridde E; Pfützner A
    Diabetes Technol Ther; 2013 Aug; 15(8):703-11. PubMed ID: 23844571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial.
    Lund SS; Tarnow L; Frandsen M; Nielsen BB; Hansen BV; Pedersen O; Parving HH; Vaag AA
    BMJ; 2009 Nov; 339():b4324. PubMed ID: 19900993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.